BREAUX LOTT LEADERSHIP GROUP for GENERAL ELECTRIC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to corporate tax reform. H.R.523 Protect Medical Innovation Act of 2013. S. 232 Medical Device Access and Innovation Protection Act. H.CON.RES.96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024. S. 2260, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BREAUX | US Senator (18 yrs), US Representative (2 yrs) |
| CHESTER TRENT LOTT | US Senator (19 yrs), US Representative (1 yr) |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Budget/Appropriations BUD
Issues relating to corporate tax reform. H.R.523 Protect Medical Innovation Act of 2013. S. 232 Medical Device Access and Innovation Protection Act. H.CON.RES.96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024. S. 2260, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BREAUX | US Senator (18 yrs), US Representative (2 yrs) |
| CHESTER TRENT LOTT | US Senator (19 yrs), US Representative (1 yr) |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.